2011 Focus on Head and Neck Cancers Conference Videos

The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 5 de mayo del 2011

Share article


Video from The Focus On Head and Neck Cancers Conference, a full day designed to address the personal and medical issues facing those with head and neck cancers; including those in treatment, survivors, their loved ones, and caregivers.

Welcome
Jason Newman, MD, FACS, Conference Co-Chair
Arati Desai, MD, MAS, Conference Co-Chair
Alexander Lin, MD, Conference Co-Chair
Kelly Malloy, MD, Conference Co-Chair
Bert O'Malley Jr, MD, Department Chair
Joseph Carver, MD, Chief of Staff, Abramson Cancer Center

Keynote Presentation: Taking Charge of your Cancer
Senator Diane Allen

Health Care Reform Briefing
Joseph Carver, MD

Latest Advancements in the Treatment of
Head & Neck Cancer

Bert O'Malley Jr, MD
Alexander Lin, MD
Harry Quon, MD

Oral Cavity and Tongue Cancer
Ara Chalian, MD
Lee Hartner, MD
Robert Lustig, MD, FACR
Kathleen Montone, MD

Oropharynx - Throat Cancer
Alexander Lin, MD
Kelly Malloy, MD
Roger Cohen, MD
Laurie Loevner, MD

Larynx - Voice Box Cancer
Arati Desai, MD, MAS
Devraj Basu, MD, PhD, FACS Laurie Loevner, MD
Harry Quon, MD

Larynx - Voice Box Cancer pt2
Arati Desai, MD, MAS
Devraj Basu, MD, PhD, FACS Laurie Loevner, MD
Harry Quon, MD

Skull Base Cancer
Jason Newman, MD, FACS Surgery (Otorhinolaryngology) Bert O'Malley Jr, MD Surgery (Otorhinolaryngology) Michelle Alonso-Basanta, MD, PhD Radiation Oncology David Mintzer, MD, FACP Medical Oncology

Integrative Medicine & Wellness - Case Conference
Jun Mao, MD, MSCE

Nutrition, Speech & Swallowing Issues
Audrey Caspar-Clark, MA, RD, CSO, LDN
Lauren Campe, MA, CCC-SLP
Patricia Dooley, MS, CCC-SLP


News
AACR: New Drug May Add to Therapy for Head and Neck CA

Sep 19, 2014 - The investigational drug alpelisib (previously known as BYL719) appears to inhibit activation of the pathway that leads to resistance to cetuximab, an anti-epidermal growth factor receptor agent used in the treatment of head and neck cancer. These findings were presented at the American Association for Cancer Research's special conference "Targeting the PI3K-mTOR Network in Cancer," held from Sept. 14 to 17 in Philadelphia.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información